论文标题
用于溶解度测量,成核统计和多晶型药物成分的模块化微流体平台:Irbesartan,Rimonabant,Aripiprazole和Sulfathiazole
Modular microfluidic platform for solubility measurement, nucleation statistics and polymorph screening of active pharmaceutical ingredients: Irbesartan, Rimonabant, Aripiprazole and Sulfathiazole
论文作者
论文摘要
药物疗效强烈依赖于活性药物成分的固态。经典的固态筛选方法涉及不同的溶剂组成和过饱和。此外,要解决成核的随机性所需的许多重复实验使得这种方法昂贵。本文提出了一个新开发的模块化微流体平台,该平台为结晶研究提供了通用且柔性的插入工具,而无需使用表面活性剂。通过溶解粉末,我们的设置生成饱和溶液,可用于溶解度测量或分布在微副细胞中。在这里,我们描述了在有机和水溶液中对药物分子(Irbesartan,Rimonabant和Aripiprazole)的不同形式进行的溶解度测量。此外,我们还提供了在水和乙腈中获得硫硫唑的成核统计量。报告了对硫唑和成核形式统计的多晶型筛查,我们发现冷却速率会影响成核和多态性结果,这反映了热力学和动力学之间的竞争。发现了三种未知的形式,其XRD模式和拉曼光谱不匹配任何引用形式。我们还通过冷却来证明微流体对结晶的局限性:减少结晶体的体积大大增加了成核诱导时间。
Drug efficacy strongly relies on the solid state of the active pharmaceutical ingredient. Classical solid-state screening methods involve different solvent compositions and supersaturations. Moreover, the many repeat experiments needed to address the stochasticity of nucleation make this approach costly. This paper presents a newly developed modular microfluidic platform that provides a universal and flexible plug-and-play tool for crystallisation studies without use of surfactants. By dissolving a powder, our setup generates saturated solutions that can be used for solubility measurements or distributed in microdroplets. Here, we describe solubility measurements performed on different forms, stable and metastable, of pharmaceutical molecules (Irbesartan, Rimonabant and Aripiprazole) in organic and aqueous solvents. In addition, we provide nucleation statistics obtained for Sulfathiazole in water and in acetonitrile. Reporting polymorph screening on Sulfathiazole and statistics for nucleated forms, we find that the cooling rate influences both nucleation and polymorphism results, reflecting the competition between thermodynamics and kinetics. Three unknown forms were discovered, with XRD patterns and Raman spectra that do not match any referenced form. We also demonstrate the limitations of microfluidics for crystallisation by cooling: reducing the crystalliser volume considerably increases nucleation induction time.